Systemic Sclerosis Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics III

Session Type: ACR Abstract Submissions
Tuesday, November 8, 2011: 2:30 PM-4:00 PM
W192b (McCormick Place West)
SessionSelect
Moderators: Tatiana Rodriguez-Reyna, MD, National Institute of Medical Sciences and Nutrition and Ariane Herrick, FRCP, School of Translational Medicine, University of Manchester, Manchester Academic Health Science Centre
Papers:
2:30 PM
Effect of Warfarin On Survival In Scleroderma-Associated and Idiopathic Pulmonary Arterial Hypertension. A Bayesian Approach to Evaluating Treatment In Uncommon Disease
Sindhu R. Johnson1, John T. Granton2, George A. Tomlinson2, Haddas Grosbein3, Thaolan Le4, Peter Lee5, M. Elizabeth Seary3, Gillian A. Hawker6 and Brian M. Feldman3, 1Toronto Western Hospital, Toronto, ON, 2University of Toronto, Toronto, ON, 3The Hospital for Sick Children, Toronto, ON, 4University Health Network Pulmonary Hypertension Programme, Toronto, ON, 5Mt. Sinai Hospital, Toronto, ON, 6Women's College Hospital, Toronto, ON
2:45 PM
Diffusion of Carbon Monoxide Predicts Survival in Systemic Sclerosis Patients with Pulmonary Hypertension and Interstitial Lung Disease
Benjamin E. Schreiber1, Chris Valerio1, Greg Keir2, Clive Handler1, Athol U. Wells2, Christopher P. Denton3 and John G. Coghlan1, 1Royal Free Hospital, London, London, United Kingdom, 2Royal Brompton Hospital, United Kingdom, 3UCL Medical School, London, United Kingdom
3:00 PM
Digital Ischemic Ulcers in Scleroderma Treated with Oral Treprostinil Diethanolamine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
James R. Seibold1, Fredrick M. Wigley2, Elena Schiopu3, Christopher D. Denton4, Richard M. Silver5, Virginia D. Steen6, Thomas A. Medsger Jr.7, Maureen D. Mayes8, Soumya Chatterjee9, Lorinda Chung10, Mary Ellen Csuka11, Dinesh Khanna3, Tracy M. Frech12, Jerry A. Molitor13, Naomi F. Rothfield14, Ariane L. Herrick15, Robert W. Simms16, Janet E. Pope17, Kristan D. Rollins18, Carl Arneson18, Michael Wade18 and on behalf of DISTOL Investigators19, 1Scleroderma Research Consultants LLC, Avon, CT, 2Johns Hopkins University, Baltimore, MD, 3University of Michigan, Ann Arbor, MI, 4Royal Free Hospital, Medical School, London, England, 5MUSC, Charleston, SC, 6Georgetown Univ Medical Center, Washington, DC, 7Univ of Pittsburgh Med Ctr, Pittsburgh, PA, 8University of Texas Health Science Center at Houston, Houston, TX, 9Cleveland Clinic, Cleveland, OH, 10Stanford Univ Medical Center, Palo Alto, CA, 11Medical College of Wisconsin, Milwaukee, WI, 12University of Utah School of Medicine, SLC, UT, 13Univ of MN MMC108, Minneapolis, MN, 14University of Connecticut, Farmington, CT, 15School of Translational Medicine, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom, 16Boston University School Medical, Boston, MA, 17St. Joseph's Health Care, University of Western Ontario, London, ON, 18United Therapeutics Corp, Research Triangle Park, NC, 19DISTOL Investigator Centers
3:15 PM
Microvascular Damage and Cardiac Fibrosis Detected by Heart MRI are a Hallmark of Systemic Sclerosis Heart Involvement
Tatiana Sofia Rodriguez-Reyna, Martha Morelos-Guzman, Pablo Hernandez-Reyes, Jaime Morales-Blanhir, Karla Montero-Duarte, Cynthia Martinez-Reyes, Carlos Reyes-Utrera and Jorge Vazquez-Lamadrid, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico
3:30 PM
Development and Internal Validation of a Two-Year Mortality Risk Prediction Rule in Early Diffuse Systemic Sclerosis Patients
Robyn T. Domsic1, Mary Lucas1, Stephen R. Wisniewski2, C. Kent Kwoh3, Michael J. Fine3 and Thomas A. Medsger1, 1University of Pittsburgh, Pittsburgh, PA, 2Univ of Pittsburgh, Pittsburgh, PA, 3University of Pittsburgh and Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare, Pittsburgh, PA
3:45 PM
Race and Mortality Risk in Scleroderma
Allan C. Gelber, Rebecca L. Manno, Adrianne Woods, Ami A. Shah, Francesco Boin, Laura K. Hummers and Fredrick M. Wigley, Johns Hopkins University, Baltimore, MD
See more of: ACR Abstract Submissions

To see other sessions for this day, use the date buttons to the left.